RESISTANT CANCER
Clinical trials for RESISTANT CANCER explained in plain language.
Never miss a new study
Get alerted when new RESISTANT CANCER trials appear
Sign up with your email to follow new studies for RESISTANT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First-in-Human trial tests engineered immune cells against tough pancreatic cancer
Disease control Recruiting nowThis early-stage study is testing the safety of a new cell therapy for pancreatic cancer that has come back after standard treatment. Doctors modify a patient's own immune cells (called CAR-T cells) to target a protein found on pancreatic cancer cells. The main goal is to find a …
Matched conditions: RESISTANT CANCER
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Experimental immune cell therapy tested for aggressive breast cancer
Disease control Recruiting nowThis early-stage study is testing the safety of a new type of treatment called CAR-T cell therapy for adults with triple negative breast cancer that has returned or stopped responding to other treatments. Doctors will collect a patient's own immune cells, modify them in a lab to …
Matched conditions: RESISTANT CANCER
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC